ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.54M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−200.00
Price / share
$577.68
Trade value
$115.54K
% of position
Common Stock
Shares
−700.00
Price / share
$578.80
Trade value
$405.16K
% of position
Common Stock
Shares
−1.04K
Price / share
$579.74
Trade value
$601.77K
% of position
Common Stock
Shares
−1.02K
Price / share
$580.78
Trade value
$590.65K
% of position
Common Stock
Shares
−1.65K
Price / share
$581.82
Trade value
$960.01K
% of position
Common Stock
Shares
−1.73K
Price / share
$582.78
Trade value
$1.01M
% of position
Common Stock
Shares
−427.00
Price / share
$583.83
Trade value
$249.30K
% of position
Common Stock
Shares
−676.00
Price / share
$584.77
Trade value
$395.31K
% of position
Common Stock
Shares
−778.00
Price / share
$585.99
Trade value
$455.90K
% of position
Common Stock
Shares
−542.00
Price / share
$586.93
Trade value
$318.11K
% of position
Common Stock
Shares
−740.00
Price / share
$588.00
Trade value
$435.12K
% of position
Net shares
+0.00
Net value
-$4.42M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/23/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −200.00 | $577.68 | $115.54K | 0.1% | 333.94K | 333.74K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −700.00 | $578.80 | $405.16K | 0.2% | 333.74K | 333.04K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −1.04K | $579.74 | $601.77K | 0.3% | 333.04K | 332K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −1.02K | $580.78 | $590.65K | 0.3% | 332K | 330.99K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −1.65K | $581.82 | $960.01K | 0.5% | 330.99K | 329.34K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −1.73K | $582.78 | $1.01M | 0.5% | 329.34K | 327.61K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −427.00 | $583.83 | $249.30K | 0.1% | 327.61K | 327.18K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −676.00 | $584.77 | $395.31K | 0.2% | 327.18K | 326.50K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −778.00 | $585.99 | $455.90K | 0.2% | 326.50K | 325.73K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −542.00 | $586.93 | $318.11K | 0.2% | 325.73K | 325.18K |
| Common Stock Indirect | 10/23/2026 | S · Sale | −740.00 | $588.00 | $435.12K | 0.2% | 325.18K | 324.44K |
| Total | +0.00 | -$4.42M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
166.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/23/2026 | M · Option Exercise | −9.50K | 117.76 | — | 166.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 45.60K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 40.51K | Direct |
| Total | 344.29K | 40.51K direct·303.77K indirect |